InsidersTradesSigma
Total declarations
Company
▲ Purchases (17 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
17
Disclosed sells
0
T+90 hit rate
62%
T+90 mean return
+45.8%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Kazimi A J. Insider active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 36 filings have been published. Split: 17 buys · 0 sell. Total volume traded: €807. History available since 17 March 2021. The latest transaction was disclosed on 16 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kazimi A J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
5,845 shares@ US$3.065.3% of flowCommon StockSEC:0001628280-26-019514:0
18 shares@ US$2.360.0% of flowCommon StockSEC:0001087294-26-000004:0
13 shares@ US$2.800.0% of flowCommon StockSEC:0001087294-25-000027:0
13 shares@ US$3.310.0% of flowCommon StockSEC:0001075050-25-000006:0
12 shares@ US$3.540.0% of flowCommon StockSEC:0001087294-25-000007:0
13 shares@ US$3.440.0% of flowCommon StockSEC:0001628280-25-041985:0
Canonical exit: 30 Oct 2025 (T+90)
16 shares@ US$3.560.0% of flowCommon StockSEC:0001628280-25-039400:0
Canonical exit: 29 Sept 2025 (T+90)
8 shares@ US$5.200.0% of flowCommon StockSEC:0001628280-25-034818:0
Canonical exit: 31 Aug 2025 (T+90)
8 shares@ US$4.860.0% of flowCommon StockSEC:0001628280-25-029849:0
Canonical exit: 30 Jul 2025 (T+90)
8 shares@ US$4.240.0% of flowCommon StockSEC:0001628280-25-024349:0
Canonical exit: 30 Jun 2025 (T+90)
10 shares@ US$5.540.0% of flowCommon StockSEC:0001628280-25-016742:0
Canonical exit: 1 Jun 2025 (T+90)
3,558 shares@ US$5.174.5% of flowCommon StockSEC:0001628280-25-013522:0
70 shares@ US$1.330.0% of flowCommon StockSEC:0001628280-24-052606:0
Canonical exit: 2 Mar 2025 (T+90)
76 shares@ US$1.150.0% of flowCommon StockSEC:0001628280-24-050107:0
Canonical exit: 30 Jan 2025 (T+90)
62 shares@ US$1.270.0% of flowCommon StockSEC:0001628280-24-045329:0
Canonical exit: 30 Dec 2024 (T+90)
50 shares@ US$1.380.0% of flowCommon StockSEC:0001628280-24-042115:0
44 shares@ US$1.470.0% of flowCommon StockSEC:0001214659-24-016051:0
44 shares@ US$1.470.0% of flowCommon StockSEC:0001214659-24-013689:0
25 shares@ US$1.520.0% of flowCommon StockSEC:0001214659-24-011867:0
25,710 shares@ US$1.8111.3% of flowCommon StockSEC:0001214659-24-005217:0
72 shares@ US$1.690.0% of flowCommon StockSEC:0001214659-23-017028:0
55 shares@ US$1.850.0% of flowCommon StockSEC:0001214659-23-016099:0
55 shares@ US$1.890.0% of flowCommon StockSEC:0001214659-23-014540:0
65 shares@ US$1.680.0% of flowCommon StockSEC:0001214659-23-013090:0
65 shares@ US$1.640.0% of flowCommon StockSEC:0001214659-23-012220:0
25 of 36 declarations
About Kazimi A J
KAZIMI A J is a declarant linked to Cumberland Pharmaceuticals INC, where he is Chairman and CEO. The record includes 36 filings in total, and across the recent filings held, buy transactions amount to EUR 807 and sell transactions to EUR 0, with filings dated from 2021-06-11 to 2026-03-18. The modal transaction nature shown is Acquisition.
